Category Archives: News

1933 Industries Marks the Beginning of Continuous Cultivation in Nevada with Second Harvest of Cannabis Plants Underway

1933 Industries Marks the Beginning of Continuous Cultivation in Nevada with Second Harvest of Cannabis Plants Underway

1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company, is pleased to announce that it has begun its second harvest of cannabis plants from its cultivation facility located in Las Vegas, marking the beginning of continuous harvests in Nevada.

CSE:TGIF OTCQX:TGIFF (CNW Group/1933 Industries Inc.)

“This is an important milestone for our Company as we move into full production. We have spent several months optimizing the new Las Vegas facility, enhancing our genetics programme to develop varieties of strains and cultivars to meet the demands of our consumers and we are pleased with our progress to date. With the surge in demand during the COVID-19 pandemic, we are working closely with the dispensaries and responding to our clients’ needs. We will be utilizing the current harvest for the production of our AMA branded concentrates and for our licensed brands Blonde™ and Denver Dab Co.”, remarked Mr. Chris Rebentisch, 1933 Industries CEO. He added, “We are nimble and capable of adjusting our production to meet the needs of our consumers, which gives us a competitive advantage.”

The following strains are being harvested and products will be available in licensed dispensaries throughout Nevada:

  • Afgoo x Maui Wowie
  • Ethos Hash Plant Bx1
  • ATF
  • Purple Tangie
  • Habanos OG
  • Purple Trainwreck
  • Inzane In the Membrane
  • Kosher Kush
  • GG OG
  • Plum Crazy
  • Zkittlez
  • Miss USA
  • Primo OG
  • Slimer OG
  • Rainmaker

“We have spent considerable time conducting genetics hunting and receiving valuable feedback from the market will be key when selecting the best strains to develop commercially.  We are known for producing some of the best concentrates in the market and we are working diligently, testing new strains and ensuring that we are harvesting every two to three weeks”, said Mr. Ryan George, Director of Cultivation at Alternative Medicine Association, the Company’s cultivation arm. “We are also pleased to report that we are growing DNA Genetics strains in every zone, with flowers available in the coming weeks and months. The Jack Herer strain will be ready for sale in approximately four months.”

The timing for harvesting cannabis flowers is critical to ensure quality and consistency. Drying, lab testing and preparing the product for sale takes roughly a month from harvest, meaning that product from this harvest will be available in the market by the end of April. The Company’s vertically integrated model focuses on controlling the supply chain where appropriate. Continuous harvests and steady-state production results in fewer purchases from and reliance on third-party biomass, improved quality of input materials, more consistent products and lower costs of production.

About 1933 Industries Inc.
1933 Industries is a vertically-integrated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing, and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners.

Our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates as well as CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™ products. Partners under licensing agreements include: Birdhouse Skateboards™, Blonde™ Cannabis, Bloom™, Denver Dab Co., Grizzly Griptape, OG DNA Genetics, The Pantry Company, PLUGplay, and The Original Jack Herer®.

The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG LLC. 1933 Industries continues to focus its operations in the licensed US cannabis industry as a multi-state operator in Nevada, Colorado and California. The Company operates in California via a management services agreement with Green Spectrum Trading Inc., a medicinal and recreational cannabis business licensee in the state.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on   1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.


View original content to download multimedia:

SOURCE 1933 Industries Inc.

Published at Mon, 30 Mar 2020 12:31:51 +0000

The Green Organic Dutchman Receives Health Canada License Amendment for Its Ancaster Processing Facility

The Green Organic Dutchman Receives Health Canada License Amendment for Its Ancaster Processing Facility

The National Institute of Drug Abuse (NIDA) has released a request for information, inviting comments from “the scientific community and other interested parties,” to help establish a standard dose for tetrahydrocannabinol (THC), the primary psychoactive constituent in cannabis, to improve cannabis research, according to a report from Cannabis News Wire.

In the notice published March 23, NIDA acknowledges the complexity of the plant and how effects vary between individuals, methods of consumption and phytochemical ratios, but emphasizes the critical necessity of establishing and implementing a “standard unit dose” for “rigorous cannabis research.” The notice cites published commentary by NIDA director Dr. Nora Valkow on the subject:

“These complexities hardly negate the value of having a standardized measure of THC, irrespective of product type. In fact, having and using such a standard is a prerequisite for comparing the effects of various cannabis products on THC bioavailability, pharmacokinetics and pharmacological effects, which is knowledge fundamental to studies pertaining to medical use of cannabis.”

NIDA and the National Institutes of Health (NIH), its parent organization, seek comments on any of the following topics:

  • 5 milligrams as a standard THC dose irrespective of route of consumption
  • Challenges and benefits to conducting research using a standard unit dose of THC including:
    • Comparability across studies, including accurate data collection and publication of methods and results
    • Comparability with legacy datasets and surveillance measures (e.g., MTF, NSDUH, YRBS)
    • Benefits and limitations of a standard unit dose that does not depend on route of administration and/or other cannabinoid constituents
    • Implementation in human laboratory and/or clinical studies
    • Implementation in observational and/or epidemiological studies
      • Labeling requirements for cannabis products
      • Education of users to acquire accurate data
  • Any other topic the respondent feels is relevant for NIDA to consider in establishing a standard unit dose of THC.

Submit a response:

Responses to this request for information must be submitted electronically via: and received by May 1, 2020.

Direct inquiries to:

Ruben Baler
National Institute on Drug Abuse (NIDA)

Published at Mon, 30 Mar 2020 19:00:00 +0000

Arizona MJ Activists Have More Than Enough Signatures To Put Legalization On Ballot, They Say

Arizona MJ Activists Have More Than Enough Signatures To Put Legalization On Ballot, They Say

At a time when drug policy reform campaigns across the country are suspending efforts amid the coronavirus pandemic, marijuana activists in Arizona say they’ve already collected more than enough signatures to qualify a legalization measure for the state’s November ballot.

The Smart and Safe Arizona campaign to legalize cannabis for adult use said it has gathered more than 320,000 signatures—about 80,000 more than is required to make the ballot.

“We’re confident that we’re over the number that we need,” Campaign Manager Stacy Pearson told Marijuana Moment in a phone interview on Thursday, adding that while the state only verifies signatures after they’re submitted, internal validation by the campaign signals that they’re well ahead of where they need to be to qualify the measure.

In the meantime, the campaign is putting a pause on further signature collection, citing concerns about the COVID-19 outbreak.

Read More

Published at Fri, 27 Mar 2020 18:42:16 +0000

Declaring CB ‘essential’ marks a watershed moment in history

Declaring CB ‘essential’ marks a watershed moment in history

The COVID-19 pandemic has forced government officials to make life-or-death decisions about which goods and services are essential, and which are not.

Essential businesses stay open; those not on the list must close to the public.

In state after state, and province after province, regulators have declared medical marijuana essential. This is a watershed moment worth noting.

In California, New York, Washington, Illinois, Massachusetts, Colorado, Nevada, Michigan, New Jersey, Pennsylvania, and Ohio, governors have closed non-essential businesses, but specifically allowed medical (and sometimes adult-use) cannabis dispensaries to remain open.

Read More

Published at Fri, 27 Mar 2020 18:53:46 +0000

CannTrust Provides Default Status Report

CannTrust Provides Default Status Report

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST, NYSE: CTST) today provided a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”), which require the Company to provide bi-weekly updates until such time as the Company is current with its filing obligations under Canadian securities laws. As previously announced, the Company is subject to a management cease trade order (“MCTO”) issued by the Ontario Securities Commission. The MCTO prohibits the directors and executive officers of the Company from trading in or acquiring securities of the Company until two full business days after the Company files an interim financial report for the three and six month periods ended June 30, 2019, an interim management’s discussion and analysis for the corresponding period and certifications of interim filings. The MCTO does not affect the ability of investors who are not insiders to trade in the Company’s securities.

CannTrust Holdings Inc. (CNW Group/CannTrust Holdings Inc.)

CannTrust remains in default of its disclosure obligations under securities legislation, has no meaningful revenues, has terminated or laid-off a significant portion of its workforce, is facing a variety of regulatory investigations, and has significant contingent liabilities in both Canada and the United States, including for potential civil damages and potential criminal, quasi-criminal or administrative penalties and fines, which cannot be reasonably quantified.

As of March 20, 2020, CannTrust had a cash balance of approximately $145 million. CannTrust and its Board of Directors continue to monitor the Company’s cash balance and other factors carefully to, among other things, assess various strategic alternatives while pursuing the Company’s remediation work. CannTrust reiterated that the nature, timing, and outcome of the Board of Directors’ ongoing strategic review process will be influenced by, among other things, the Company’s ability to extend or renew insurance coverage on acceptable terms, whether or when Health Canada reinstates the Company’s licenses, how long it will take to restore operations and expectations regarding the resolution of the Company’s contingent liabilities, and potential civil, criminal, quasi-criminal, administrative and regulatory actions in both Canada and the United States. In addition, the COVID-19 pandemic could adversely affect the completion of the Company’s remediation plan for its Vaughan facility and Health Canada’s consideration of the adequacy of CannTrust’s submissions for reinstatement of the Company’s license for its Niagara facility. Ultimately, any decision to reinstate the Company’s licenses, and the timing and conditions of any such reinstatement, will rest solely with Health Canada. No assurance can be given that Health Canada will reinstate the Company’s licenses at either its Niagara or Vaughan Facilities.

As previously announced, the Toronto Stock Exchange has advised CannTrust that a meeting of its Listings Committee will be held on April 14, 2020 to consider whether to delist the Company’s securities.

CannTrust further noted that:


Other than as disclosed above, there have been no material changes to the information contained in the Company’s August 16, 2019 news release, August 29, 2019 news release, September 12, 2019 news release, September 26, 2019 news release, October 10, 2019 news release, October 24, 2019 news release, November 7, 2019 news release, November 21, 2019 news release, December 5, 2019 news release, December 19, 2019 news release, January 2, 2020 news release, January 16, 2020 news release, January 30, 2020 news release, February 13, 2020 news release, February 27, 2020 news release, and March 12, 2020 news release;


The Company intends to continue to comply with the alternative information guidelines of NP 12-203; and,


Except as previously disclosed, there are no subsequent specified defaults (actual or anticipated) within the meaning of NP 12-203.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian Securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable United States safe harbor laws, and such statements are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information and statements in this news release include statements relating to the corrective actions being taken by the Company, and Health Canada’s pending determinations. Forward-looking information and statements necessarily involve known and unknown risks, including, without limitation: actions taken in respect of the Company’s products by its customers and regulators; results of Health Canada’s investigation, including orders and compliance measures required by Health Canada and their impact on the operations, inventory, assets and financial condition of the Company; the Company’s implementation of remediation plans and related actions; regulatory approval; the outcome of the Company’s contingent liabilities; the impact of potential regulatory investigations; the Company’s review of strategic alternatives; risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the cannabis industry in Canada generally; and, the ability of CannTrust to implement its business strategies.

Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 28, 2019 (the “AIF”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at and filed as an exhibit CannTrust’s Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at (the “March 2019 Form 40-F”). The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements. Readers are also reminded that CannTrust remains in default of its periodic disclosure requirements under applicable securities laws and stock exchange requirements, that its most recent AIF, Form 40-F and other disclosures do not reflect all risk factors that currently face the Company, and that the Company has not completed or filed the restatements of the financial statements included in the AIF or the March 2019 Form 40-F or otherwise filed an amendment to such Form 40-F.

The TSX and NYSE do not accept responsibility for the adequacy or accuracy of this release.


View original content to download multimedia:

SOURCE CannTrust Holdings Inc.

Published at Fri, 27 Mar 2020 11:27:31 +0000

DEA Takes Steps to Approve Cannabis Cultivation Applications, States Issue New Rules for Industry Amid COVID-19 Concerns: Week in Review

DEA Takes Steps to Approve Cannabis Cultivation Applications, States Issue New Rules for Industry Amid COVID-19 Concerns: Week in Review

The COVID-19 pandemic is forcing governments worldwide to take drastic measures to “flatten the curve” and reduce economic fallout, and Canada is no exception. The Great White North closed its border with the U.S. for all non-essential travel (goods are not included in that shutdown), shuttered schools, colleges and universities across the country, and provinces are taking steps to stop all non-essential businesses.

The Canadian cannabis industry, for the most part, can operate as normally as it can. Dispensaries are conducting business with social distancing measures in place, deliveries can be made—although Canada Post will no longer deliver cannabis packages to purchasers’ homes, opting instead for postal office pickup to minimize delivery person exposure—and cultivation sites continue to operate. 

Both the Quebec and Ontario governments have deemed cannabis cultivation and retail businesses “essential” to the marketplace and, as such, can remain open during each province’s mandatory shutdown. Other provinces such as Alberta are considering similar proposals. 

Some companies, however, are taking extra steps to ensure their employee’s, patients and consumers safety. For example, Canopy Growth, a vertically integrated LP, closed its retail storefronts on March 17. “We have a responsibility to our employees, their families, and our communities to do our part to “flatten the curve” by limiting social interactions. For us, that means shifting our focus from retail to e-commerce,” said David Klein, Canopy’s CEO, in a press release. “This is a big decision but it was also an easy one to make – our retail teams are public-facing and have been serving an above-average volume of transactions in recent days. Given the current situation, it is in the best interest of our teams and our communities to close these busy hubs until we are confident we can operate our stores in the best interest of public health.” 

The company is keeping its cultivation operations open but is asking that all employees who can work remotely do so, said Canopy’s VP of Communications Jordan Sinclair in a March 24 email to CBT. The company recently closed facilities in Aldergrove and Delta, British Columbia, and scrapped plans for a third greenhouse at its Niagara-on-the-Lake location in Ontario, both unrelated to the COVID-19 outbreak.

Amid a reported surge in demand, Aurora Cannabis’ “production facilities remain fully operational and … have not experienced any disruptions to regular operations, including [to the] existing supply chain,” said Michelle Lefler, Aurora’s VP of Communications in a March 20 email to CBT. The company is taking steps to mitigate risks, Lefler said, including “implementing good hygiene practices and illness prevention measures across our organization.”

She added that, “at this time, we have paused all business travel and have advised staff to defer personal travel, which we are carefully monitoring. Employees are being provided the option to work from home as per the social distancing procedures advised by the World Health Organization. The company will adapt further guidance to employees as necessary.”

As the Canadian cannabis industry does its part to help the country’s fight against the pandemic, some are feeling left out by the federal government’s lack of resources available to cannabis producers and retailers. As LPs, like the rest of the world, try to figure out how to best navigate the COVID-19 pandemic, the Canadian government announced that cannabis businesses will not be eligible for business relief funds.

Dan Sutton, CEO of Tantalus Labs, another LP, has been in correspondence with both the Business Development Bank of Canada (BDC), a government-owned development bank, and Farm Credit Canada (FCC), the country’s largest agricultural term lender. Neither have indicated a willingness to work with smaller cannabis firms, he says.

“We confirmed on Friday that BDC remains in their position that ‘we do not do business with cannabis firms at this time,’” Sutton said in a March 23 email to CBT. “Today, our file was taken to credit with FCC who confirmed that their preference is to ‘focus on portfolio companies.’ To my knowledge, there are five firms in Canadian cannabis that currently do business with FCC, so this is not the stimulus lifeline the industry needs right now.”

He added that without provincial and/or federal assistance, “many firms will perish in the economic fallout and liquidity crunch from COVID-19.”

The Alberta Cannabis Council (ACC), a not-for-profit industry trade group serving the province’s cannabis industry stakeholders, shared a letter signed by 74 industry stakeholders with the Canadian government calling for legislators to grant the same access to economic relief programs to the country’s cannabis industry. 

“We are not asking for special treatment, but rather equitable treatment,” the signatories said.

Published at Sat, 28 Mar 2020 12:00:00 +0000

Sundial Growers to Reschedule Fourth Quarter and Fiscal Full-Year 2019 Financial Results to March 30, 2020

Sundial Growers to Reschedule Fourth Quarter and Fiscal Full-Year 2019 Financial Results to March 30, 2020

Sundial Growers Inc. (Nasdaq: SNDL) (“Sundial” or the “Company”) announced today that it will reschedule the release of its fourth quarter and fiscal full-year 2019 financial results and investor conference call to allow for ongoing discussions with our lenders regarding modifications to our credit agreements. The rescheduled call and webcast will take place on March 31, 2020 at 10:30 a.m. EDT (8:30 a.m. MDT) and the Company will release earnings after market close on March 30, 2020.

The rescheduling of the release of Sundial’s 2019 year-end financial reporting is not related to the completion of our financial results.


Callers may access the conference call via the following phone numbers:

Canada/USA Toll Free: 1-800-319-4610

International Toll: +1-604-638-5340

UK Toll Free: 0808-101-2791

Callers should dial in 5-10 minutes prior to the scheduled start time.


To access the live conference call webcast, please visit the following link:

A replay will be available for three months following the conference call.

About Sundial Growers Inc.

Sundial is a public company with Common Shares traded on Nasdaq under the symbol “SNDL”. Sundial is a licensed producer that proudly crafts the world’s finest cannabis using state-of-the-art indoor facilities. Our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced master growers set us apart.

Our Canadian operations cultivate high-quality, small-batch cannabis using an individualized “room” approach, with 470,000 square feet of total space. In the United Kingdom, we grow high-quality, traceable plants, including hemp, ornamental flowers and edible herbs with 1.75 million square feet of environmentally friendly facilities.

Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Our consumer-packaged goods experience enables us to not just grow top quality cannabis, but also create exceptional consumer and customer experiences.

We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds, AB, and Rocky View County, AB.

SOURCE Sundial Growers Inc.

Cision View original content:

Media Contact: Sophie Pilon, Corporate Communications Manager, Sundial Growers Inc., O: 1.587.327.2017, C: 1.403.815.7340, E:; Investor Relations Contact: Jayson Moss, Investor Relations, Sundial Growers Inc., C: 1.604.375.3599, E: jmoss@sundialgrowers.comCopyright CNW Group 2020

Source: Canada Newswire (March 27, 2020 – 7:30 AM EDT)

News by QuoteMedia

Published at Fri, 27 Mar 2020 11:43:27 +0000

Canadian Cannabis Firms Brace for COVID-19, Potential Fallout

Canadian Cannabis Firms Brace for COVID-19, Potential Fallout

In the wake of the COVID-19 global pandemic, U.S. and Canadian cannabis companies have a unique opportunity to aid those in need. Not only are their cannabis products increasingly being deemed essential by governments—but they also have the facilities, personnel and protocols already in place to fill the desperate need for medical supplies. 

These three companies are using those advantages to help their communities.

Aloha Green Apothecary

Photo courtesy of Aloha Green Apothecary

In Hawaii, Aloha Green Apothecary is producing hand sanitizer for its employees and patients, with plans to ramp up production as much as possible to donate hand sanitizer to other businesses and organizations in the state.

“We’re just trying our best to meet our patients’ needs and follow the law with all the changes in law that the government is laying down,” Tai Cheng, a spokesperson for Aloha Green Apothecary, told Cannabis Business Times.

The vertically integrated company, located in Oahu, has been deemed essential after all non-essential businesses were ordered to shut down. And since the outbreak, sales have increased.

Aloha Green Apothecary has always maintained strict security and sanitation protocols, but the company has implemented additional measures as a result of the COVID-19 outbreak. Hand sanitizer has always been available near the entrance and exit of the dispensary, Cheng said, but the team placed hand sanitizer at every point-of-sale station amid coronavirus concerns, which meant the company needed a larger supply. As local stores started selling out, Aloha Green Apothecary tried to buy hand sanitizer from its wholesalers and distributors, but they, too, were sold out.

The Aloha Green Apothecary team then started hearing reports from patients that they were lining up outside big box stores early in the morning to purchase hand sanitizer, and that stores were implementing purchase limits. That’s when the company decided to make hand sanitizer and provide it to patients for free.

Photo courtesy of Aloha Green Apothecary

Aloha Green Apothecary dedicated its ethanol, mixing systems, worktables and filling machines to hand sanitizer production in order to provide hand sanitizer to its employees and patients.

“We’re sitting on a lot of ethanol and other alcohols because of the extraction process,” Cheng said. “We had a lot of ethanol available in our lab, and the scientists in the lab said it’s not too difficult to make hand sanitizer. We just have to make sure it meets at least 60% alcohol content to be effective, according to the [World Health Organization]. We already make topicals … [and] a bunch of [other products] that are similar. We just don’t make a cleanser, but we thought, why not? We’ll give it a try so we can at least stock up our own retail dispensaries with sanitizer, as well as our office.”

Cheng said the company stopped making its topicals altogether to dedicate its mixing system, worktables and filling machines to hand sanitizer production.

“We have a lot [of ethanol], but of course all these alcohols are in high demand as supply chains are disrupted because of the coronavirus,” Cheng said. “We have no risk of running out with just our patients, but we have received inquiries from the state government, local convenience store chains, and other offices and businesses to supply them with sanitizer, just because they’re running out, as well. So, we’re going to try our best to maintain our ability to give sanitizer away for free to our current patients, and we’re going to try to make [a] larger volume [of] sanitizer to give away to some of those offices and companies so they can maintain some safety for their employees.”


Similarly, CannaCraft in Santa Rosa, Calif., found itself in dire need of hand sanitizer for its own employees and to ensure safety during retail deliveries.

After cannabis companies in California were deemed essential, CannaCraft started implementing the same types of extra sanitation measures, including splitting shifts, work-from-home policies where possible, as well as extreme sanitation of “any doorknob, faucet handle or coffee maker or phone, printer—anything more than one person was touching,” Tiffany Devitt, CannaCraft’s President of Wellness, said.

The company also wanted to make sure sanitation extended beyond the facility and into dispensaries, not only for deliveries but also for dispensary staff and consumer access. Hand sanitizer immediately came to mind.

Like Aloha Green Apothecary, CannaCraft’s team already procures ethanol that they use for product manufacturing at their 40,000-square-foot facility. Similarly, because they produce topicals, they had other valuable items on-hand already, like aloe, and thousands of pump containers, which coincidentally were leftover from the state’s “pre-regulatory era,” Devitt said. “We had initially used them for our topicals, but they weren’t child resistant, so we discontinued that packaging … That was sort of a delightful consequence of regulation.”

Plus, being so highly regulated, their facility was well-equipped for the task. They’re frequently inspected by

Photo courtesy of CannaCraft

CannaCraft pulled its R&D team off its current projects and tasked them with formulating and filling hand sanitizer under the company’s Care by Design brand.

the California Department of Public Health and the Sonoma County Department of Health Services. Sometimes those inspections last up to seven hours. Having well-documented procedures and training is “second nature” to CannaCraft, Devitt said.

CannaCraft pulled its R&D team off its current projects and tasked them with formulating and filling hand sanitizer under the company’s Care by Design brand. Devitt said having PhDs and regulatory liaisons on staff helped this process go smoothly. The Food and Drug Administration (FDA) also loosened up its regulatory guidelines to make it easier for people to respond in real-time to the crisis, she adds, so the team was able to produce a formula and quickly ensure it complied with FDA guidelines.

The first batch of hand sanitizer CannaCraft produced went home with employees for their families. The second batch is being shipped out directly to dispensary customers with their orders. The company has also gotten several requests from local nonprofits, especially those who work with the elderly population, and so they’ll work to distribute those as they’re able. All the hand sanitizer produced by CannaCraft will be donated.

Interestingly, the manufacturing of the hand sanitizer did not significantly impact production of CannaCraft’s cannabis products, Devitt said, adding, “We have about 150 different products, so tossing one more product in did not ruffle them in the least.”

Keirton, Inc. (Twister Trimmer)

Even companies in the cannabis supply chain that aren’t plant-touching are offering up ways to be of service during the pandemic.

Product engineering and idea development company Keirton, Inc., which produces Twister Trimmer cannabis trimming equipment and has facilities in Surrey, British Columbia and Ferndale, Wash., has opened up a call to its supply chain to offer networking, as well as its facilities, to assist in the making of ventilators.

Last week, Keirton, Inc. CEO Jay Evans posted to LinkedIn making the announcement: 

“During these difficult times, I believe it’s incredibly important for people to pull together to make a difference. It’s been said that ‘Necessity is the Mother of Invention.’ At Keirton, innovation has been in our DNA since day one. We have thirteen years of industry expertise in creating precision electromechanical machines used in Health Canada regulated GMP facilities across our country and EU-GMP facilities across Europe. Today, we are in a good position to temporarily pivot on our core range of products and assist in the much needed development of medical ventilators.”

Soon after, comments began pouring in from consultants, manufacturing companies and horticulture companies, offering ideas and suggestions to help get the idea rolling. Evans told Cannabis Business Times in an interview that the company has now been in touch with the Canadian federal government and added to a list of supporters; has been supporting some companies in the design phase of ventilators; and is open to using their production space in B.C. for their manufacture if that bandwidth is needed.

“We realized we have the expertise to design something quite quickly, especially if the government would open source the design for us,” Evans told Cannabis Business Times in an interview. “We could design it, produce it and start manufacturing quite fast.”

Keirton, Inc. has PhDs, chemists and engineers on staff, access to a clean room, and vendors from around the globe, Evans said, but their biggest advantage, he says, is their ability to adapt in these unprecedented times. “We’re very nimble. We’re not a huge company so we’re able to maneuver quickly,” he said.

In the meantime, demand has also shot up for its trimming equipment as cannabis companies are trying to keep up with production. “One of the things we can help companies with is bringing some of our solutions to them, and not replacing their people, but augmenting the people they have in making them more productive and allowing them to use those people in more high-value areas of business,” Evans said.

Evans added that he doesn’t anticipate the balance between ventilator assistance and the current manufacturing of its trimming equipment will be an issue, given the company has inventory in place and extra capacity if necessary. He added that potential layoffs in other sectors may help provide opportunities for support if the extra capacity is needed.

“It’s important for us, cannabis being deemed an essential service that the industry keeps supplying quality, safe cannabis and we can help anyone out there who needs that assistance, either with our equipment or our advice,” Evans said. “Anywhere we can help, we’d love to help.”

Published at Thu, 26 Mar 2020 17:48:00 +0000

How to get a medical MJ card in Massachusetts

How to get a medical MJ card in Massachusetts

Check your symptoms and conditions against the state’s list of qualifying conditions.

Massachusetts’ medical cannabis law was updated in late 2019 to give health care providers a greater ability to determine each patient’s need for medical marijuana.

Some of the main qualifying conditions include, but are not limited to: cancer, glaucoma, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis C, amyotrophic lateral sclerosis (ALS), Crohn’s disease, Parkinson’s disease, and multiple sclerosis (MS), when such diseases are debilitating.

The law also allows registered health care providers to recommend medical marijuana for “other debilitating conditions as determined in writing by a Qualifying Patient’s healthcare provider.” Debilitating is defined in the law as “causing weakness, cachexia, wasting syndrome, intractable pain, or nausea, or impairing strength or ability, and progressing to such an extent that one or more of a patient’s major life activities is substantially limited.”

Read More

Published at Wed, 25 Mar 2020 18:23:19 +0000

goPuff Executive, Christopher DeSousa Joins Driven Deliveries’ Board of Directors

goPuff Executive, Christopher DeSousa Joins Driven Deliveries’ Board of Directors

 Driven Deliveries Inc. (the “Company” or Driven) (OTC: DRVD), California’s fastest growing online cannabis retailer and direct-to-consumer logistics company, announced today that Christopher DeSousa has joined the company’s Board of Directors.

Christopher DeSousa is a senior operator and supply chain executive with nearly 20 years of industry experience in third-party logistics, distribution, transportation, final mile delivery, manufacturing, retail operations, and e-commerce.  He currently serves as the Head of Operations for goPuff, a digital convenience retailer.  goPuff is the first convenience store application to provide door-to-door “hyper-fast delivery” of items, typically within 15-20 minutes of ordering.

DeSousa is responsible for overseeing goPuff’s field and delivery operations, which consist of micro-fulfillment centers and a gig economy driver partner workforce.  He also leads several teams at the company’s Philadelphia headquarters including driver operations, loss prevention, safety, lean & continuous improvement, and training.

Prior to joining goPuff, DeSousa has held several senior-level leadership roles at C.H. Robinson, Echo Global Logistics, and DSC Logistics (now CJ Logistics), including most recently as Vice President of Global Logistics at Sleep Number Corporation.  Two common themes from throughout his career have been a relentless focus on improving the customer experience, and growth; either in start-up companies or by building innovative new products and services in mature organizations to unlock new revenue streams and expand margin.

DeSousa earned his B.S. degree in Operations and Information Systems Management from the Smeal College of Business at the Pennsylvania State University in 2002.  He also earned his M.B.A. degree from the Carlson School of Business at the University of Minnesota in 2019.

“We are excited to have Christopher join the Board,” said Christian Schenk, CEO & Chairman of the Board of Directors,  Driven Deliveries Inc.  “His experience in market expansion, as well as his participation in mergers and acquisitions along with supporting large scale capital fundraising, will be instrumental in our next phase of growth.” he added.

About Driven:

Driven Deliveries, Inc., is the first publicly traded cannabis delivery service operating within the United States. Founded by experienced technology and cannabis executives, the company provides e-commerce solutions, online sales, and on-demand cannabis delivery, in select cities where allowed by law. Driven offers legal cannabis consumers the ability to purchase and receive their marijuana in a fast and convenient manner. By 2020, legitimate cannabis revenue in the U.S. market is projected to hit $23 billion. By leveraging consumer trends, and offering a proprietary, turnkey delivery system to its customers, management believes it is uniquely positioned to best serve the needs of the emerging cannabis industry and capture notable market share within the sector. For more information, please visit and review Driven’s filings with the U.S. Securities and Exchange Commission.

Forward-looking Statements:

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations, and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that we will achieve these plans, objectives, expectations or intentions. Forward-looking statements involve significant risks and uncertainties (some of which are beyond the Company’s control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the company’s filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: Maddie



View original content to download multimedia:

SOURCE Driven Deliveries, Inc.


Share - Facebook

Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Wed, 25 Mar 2020 11:41:42 +0000